Literature DB >> 23929205

Mechanistic links between aging and lung fibrosis.

Victor J Thannickal1.   

Abstract

Our understanding of the biology of aging has advanced significantly in recent years. This has resulted in the recent formulation of the "hallmarks of aging" that include genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication. Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease that results from the accumulation of scar tissue in the lungs of affected individuals. IPF is a disease of aging that most commonly affects human subjects older than 60 years of age. While progress has been made in elucidating key pathological processes in IPF, the relationship of these processes to those that occur during aging are not well defined. In this review, we explore existing and emerging paradigms in the pathogenesis of IPF in light of the recently defined hallmarks of aging.

Entities:  

Mesh:

Year:  2013        PMID: 23929205      PMCID: PMC3852192          DOI: 10.1007/s10522-013-9451-6

Source DB:  PubMed          Journal:  Biogerontology        ISSN: 1389-5729            Impact factor:   4.277


  79 in total

Review 1.  Epithelial stem cell exhaustion in the pathogenesis of idiopathic pulmonary fibrosis.

Authors:  M Chilosi; C Doglioni; B Murer; V Poletti
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2010-07       Impact factor: 0.670

2.  Idiopathic pulmonary fibrosis: a disorder of lung regeneration?

Authors:  Victor J Thannickal; James E Loyd
Journal:  Am J Respir Crit Care Med       Date:  2008-10-01       Impact factor: 21.405

3.  Incidence and prevalence of idiopathic pulmonary fibrosis.

Authors:  Ganesh Raghu; Derek Weycker; John Edelsberg; Williamson Z Bradford; Gerry Oster
Journal:  Am J Respir Crit Care Med       Date:  2006-06-29       Impact factor: 21.405

4.  Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis.

Authors:  Marco Chilosi; Venerino Poletti; Alberto Zamò; Maurizio Lestani; Licia Montagna; Paola Piccoli; Serena Pedron; Manuela Bertaso; Aldo Scarpa; Bruno Murer; Alessandra Cancellieri; Roberta Maestro; Gianpietro Semenzato; Claudio Doglioni
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

5.  Interstitial lung disease in patients with ataxia-telangiectasia.

Authors:  Scott A Schroeder; Michael Swift; Claudio Sandoval; Claire Langston
Journal:  Pediatr Pulmonol       Date:  2005-06

Review 6.  Autophagy and aging.

Authors:  David C Rubinsztein; Guillermo Mariño; Guido Kroemer
Journal:  Cell       Date:  2011-09-02       Impact factor: 41.582

7.  Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis.

Authors:  Charlene D Fell; Fernando J Martinez; Lyrica X Liu; Susan Murray; Meilan K Han; Ella A Kazerooni; Barry H Gross; Jeffrey Myers; William D Travis; Thomas V Colby; Galen B Toews; Kevin R Flaherty
Journal:  Am J Respir Crit Care Med       Date:  2010-01-07       Impact factor: 21.405

8.  Insufficient autophagy in idiopathic pulmonary fibrosis.

Authors:  Jun Araya; Jun Kojima; Naoki Takasaka; Saburo Ito; Satoko Fujii; Hiromichi Hara; Haruhiko Yanagisawa; Kenji Kobayashi; Chikako Tsurushige; Makoto Kawaishi; Noriki Kamiya; Jun Hirano; Makoto Odaka; Toshiaki Morikawa; Stephen L Nishimura; Yoshinori Kawabata; Hiroshi Hano; Katsutoshi Nakayama; Kazuyoshi Kuwano
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-10-19       Impact factor: 5.464

Review 9.  Mitochondrial DNA mutations in disease and aging.

Authors:  Chan Bae Park; Nils-Göran Larsson
Journal:  J Cell Biol       Date:  2011-05-23       Impact factor: 10.539

Review 10.  Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis.

Authors:  Jonathan A Kropski; William E Lawson; Lisa R Young; Timothy S Blackwell
Journal:  Dis Model Mech       Date:  2013-01       Impact factor: 5.758

View more
  48 in total

Review 1.  Fibrosis: ultimate and proximate causes.

Authors:  Victor J Thannickal; Yong Zhou; Amit Gaggar; Steven R Duncan
Journal:  J Clin Invest       Date:  2014-11-03       Impact factor: 14.808

Review 2.  The Role of Aging in Idiopathic Pulmonary Fibrosis.

Authors:  Joseph Leung; Young Cho; Richard F Lockey; Narasaiah Kolliputi
Journal:  Lung       Date:  2015-04-23       Impact factor: 2.584

3.  Age-dependent dysregulation of redox genes may contribute to fibrotic pulmonary disease susceptibility.

Authors:  Evan A Elko; J Matthew Mahoney; Pamela Vacek; Albert van der Vliet; Vikas Anathy; Jos L J L van der Velden; Yvonne M W Janssen-Heininger; David J Seward
Journal:  Free Radic Biol Med       Date:  2019-07-14       Impact factor: 7.376

Review 4.  Molecular determinants of mesenchymal cell activation in fibroproliferative diseases.

Authors:  Loka R Penke; Marc Peters-Golden
Journal:  Cell Mol Life Sci       Date:  2019-09-28       Impact factor: 9.261

5.  Getting to the core of fibrosis: targeting redox imbalance in aging.

Authors:  Louise Hecker; Victor J Thannickal
Journal:  Ann Transl Med       Date:  2016-03

6.  Epithelial to mesenchymal transition-related proteins ZEB1, β-catenin, and β-tubulin-III in idiopathic pulmonary fibrosis.

Authors:  Marco Chilosi; Anna Caliò; Andrea Rossi; Eliana Gilioli; Federica Pedica; Licia Montagna; Serena Pedron; Marco Confalonieri; Claudio Doglioni; Rolf Ziesche; Markus Grubinger; Wolfgang Mikulits; Venerino Poletti
Journal:  Mod Pathol       Date:  2016-09-02       Impact factor: 7.842

7.  ENERGY SENSING PATHWAYS IN AGING AND CHRONIC LUNG DISEASE.

Authors:  Victor J Thannickal
Journal:  Trans Am Clin Climatol Assoc       Date:  2020

Review 8.  Systemic sclerosis-associated fibrosis: an accelerated aging phenotype?

Authors:  Tracy R Luckhardt; Victor J Thannickal
Journal:  Curr Opin Rheumatol       Date:  2015-11       Impact factor: 5.006

Review 9.  TGF-β1 Signaling and Tissue Fibrosis.

Authors:  Kevin K Kim; Dean Sheppard; Harold A Chapman
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

Review 10.  New therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses.

Authors:  Neil Ahluwalia; Barry S Shea; Andrew M Tager
Journal:  Am J Respir Crit Care Med       Date:  2014-10-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.